Clinical Trial Update: To Assess the Anti-adhesive Effect and Safety of Protescal [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the anti-adhesive effect and safety of Protescal in laparoscopic myomectomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Protescal

Snippet

Sponsor: LG Life Sciences | Conditions: Laparoscopic Myomectomy | Phase 3 | Status: TERMINATED